Certain Shares of Xbrane Biopharma AB (publ) are subject to a Lock-Up Agreement Ending on 21-AUG-2023. These Shares will be under lockup for 90 days starting from 23-MAY-2023 to 21-AUG-2023.

Details:
In connection with the Transaction, the Company has, subject to customary exceptions, agreed to a lock-up undertaking on future share issuances for a period of 90 days following completion of the Directed Share Issue. Members of the Company?s Board of Directors and management, have, subject to customary exceptions, agreed to not sell their shares in the Company for a period of 90 days after the date of registration of the shares issued in connection with the Directed Share Issue with the Swedish Companies Registration Office. Existing shareholders Serendipity Group AB and STADA Arzneimittel AG have, subject to customary exceptions, agreed to not sell their shares in the Company for a period of 90 calendar days after the date of registration of the shares issued in connection with the Directed Share Issue with the Swedish Companies Registration Office.